Elsevier

Cytotherapy

Volume 1, Issue 5, January 1999, Pages 377-388
Cytotherapy

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cellsThe European ISHAGE Working Group for Standardization of Tumor Cell Detection

https://doi.org/10.1080/0032472031000141283Get rights and content

Background

Detection of isolated tumor cells (TC) in BM from carcinoma patients can predict future relapse. Various molecular and immunocytochemical (ICC) methods have been used to detect these cells, which are present at extremely low frequencies of 10−5−10−6. The specificity and sensitivity of these techniques may vary widely. In 1996, a European ISHAGE Working Group was founded to standardize and optimize procedures used for the detection of minimal residual disease. We have attempted to develop objective criteria for the evaluation of immunocytochemi-cally identifiable cancer cells.

Methods

An interlaboratory ring experiment was performed, to compare the screening and detection of micrometastasis-positive events between different laboratories. The discrepant results induced us to establish a common consensus on morphological criteria applicable to the identification of immunostained micrometastatic TC.

Results

Bared on this consensus evaluation, we propose a classification of stained elements into three groups: (1) ‘TC's show patbognomonic signs of epithelial TC-nature, as defined by a clearly enlarged nucleus or clusters of ≥ 2 immunopositive cells. (2) ‘Probable TC's represent morphological overlap between hematopoietic cells (HC) and TC which lack pathognomonic signs of TC-nature, but do not exhibit clear morphological features of HC. These cells are considered as TC if control staining with an isotype-specific, unrelated Ab is negative. (3) ‘TC-negative’ cells are defined as false positive’ HC, skin squamous epithelial cells and artefacts.

Discussion

The proposed classification of immunostained events is a first step towards the development of standardized immunocytochemical assays for the detection of occult micrometastatic TC in BM or blood.

References (17)

  • K. Pantel et al.

    Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases

    Lancet

    (1996)
  • C. Griwatz et al.

    An immuno-logical enrichment method for epithelial cells from peripheral blood

    J Immunol Methods

    (1995)
  • K. Pantel et al.

    Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow

    J Hematother

    (1994)
  • E. Borgen et al.

    Immunocytochemical detection of isolated epithelial cells in bone marrow: Non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase

    J Pathol

    (1998)
  • S. Braun et al.

    Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status

    J Natl Cancer Inst

    (1998)
  • R.J. Cote et al.

    Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases

    J Clin Oncol

    (1991)
  • R.J. Cote et al.

    Detection of occult bone marrow micrometastases in patients with operable lung carcinoma

    Ann Surg

    (1995)
  • I. Funke et al.

    Meta-analyses of studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated

    J Clin Oncol

    (1998)
There are more references available in the full text version of this article.

Cited by (270)

  • Biomarkers of minimal residual disease and treatment

    2024, Advances in Clinical Chemistry
View all citing articles on Scopus
View full text